Cart
sales@molnova.com
Camlipixant
CAS No. 1621164-74-6
Camlipixant( —— )
Catalog No. M36052 CAS No. 1621164-74-6
Camlipixant (BLU-5937) is an orally active purine P2X3 receptor antagonist that is potent, selective and competitive.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 147 | Get Quote |
|
| 5MG | 227 | Get Quote |
|
| 10MG | 370 | Get Quote |
|
| 25MG | 679 | Get Quote |
|
| 50MG | 1058 | Get Quote |
|
| 100MG | 1395 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameCamlipixant
-
NoteResearch use only, not for human use.
-
Brief DescriptionCamlipixant (BLU-5937) is an orally active purine P2X3 receptor antagonist that is potent, selective and competitive.
-
DescriptionCamlipixant (BLU-5937) a potent, selective, non-competitive and orally active P2X3 homotrimeric receptor antagonist with an IC50 of 25 nM against hP2X3 homotrimeric. Camlipixant shows potent anti-tussive effect and no taste alteration. Camlipixant can be used for the research of unexplained, refractory chronic cough.
-
In Vitro——
-
In VivoAnimal Model:Male Dunkin Hartley guinea pigsDosage:0.3, 3, 30 mg/kg Administration:PO, approximately 2 h prior to tussive agent exposure Result:Significantly reduced the histamine-induced enhancement in the number of citric acid-induced coughs. Reduced significantly and dose-dependently the ATP-induced enhancement of citric acid-induced coughs.
-
Synonyms——
-
PathwayMembrane Transporter/Ion Channel
-
TargetP2X Receptor
-
RecptorP2X Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1621164-74-6
-
Formula Weight458.46
-
Molecular FormulaC23H24F2N4O4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (218.12 mM; Ultrasonic ) DMSO : 100 mg/mL (218.12 mM; ultrasonic and adjust pH to 3 with 1M HCl )
-
SMILESC(C1=C(N=C2N1C=CC(C)=C2)C3=C(F)C=C(C(NC)=O)C=C3F)[C@H]4CN(C(OC)=O)CCO4
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Garceau D, Chauret N. BLU-5937: A selective P2X3 antagonist with potent anti-tussive effect and no taste alteration. Pulm Pharmacol Ther. 2019 Jun;56:56-62.?
molnova catalog
related products
-
AZD-9056 hydrochlori...
A potent, selective, orally bioavailable P2X7 receptor antagonist; inhibits release of pro-inflammatory mediators from isolated human peripheral monocytes (IL-1β and IL-18) and human alveolar macrophages (IL-1β) with IC50 values of 10-13 nM.
-
A-740003
A-740003 (A740003) is a potent, selective, competitive P2X7 receptor antagonist with IC50 of 40 nM and 18 nM for hP2X7 and rP2X7, respectively.
-
JNJ-55308942
JNJ-55308942 is a novel highly potent P2X7 antagonist with Ki of 1.0 and 6.5 nM for rat and human hP2X7, demonstrates significant activity against a panel of related P2X receptors (P2X1, P2X2, P2X3, P2X2/3, and P2X4; also shows insignificant inhibition of nine CYP isoforms (IC50>15 uM).
